Jeffrey A. Anderson, VP, Clinical & Regulatory at REVA Medical, Inc. (RVA), sold 7,500 shares at $5.97 ($45K) on 2012-06-05, disclosed to the SEC on 2012-06-06.
Open-market sale of $45k RVA by VP, Clinical & Regulatory. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.88 | 2,500 | $15K | 32.8% |
| 2 | $5.97 | 2,500 | $15K | 33.3% |
| 3 | $6.07 | 2,500 | $15K | 33.9% |
| Total | $5.97 avg | 7,500 | $45K | 100% |
| Filing → |
| RVA | SELL | 2012-06-14 | $31K | — | Filing → |
| RVA | SELL | 2012-05-31 | $16K | — | Filing → |